Trademarkia Logo

Canada

C$
Trademark Search in Canada
NUCLEXPO

View On IC.GC.CA

NUCLEXPO
REGISTERED

on 20 May 2020

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

KARYOPHARM THERAPEUTICS INC.

85 Wells Avenue Newton, MA 02459

US

Serial Number

1878130 filed on 18th Jan 2018

Registration Number

TMA1078698 registered on 20th May 2020

Registration expiry Date

20th May 2030

Correspondent Address

PERRY + CURRIER

1300 YONGE STREETSUITE 500TORONTO

ONTARIO

CA

M4T1X3

NUCLEXPO

Trademark usage description

pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammatory muscle and connective tissue diseases, neurodegenerative diseases Read More

Classification Information

Class [005]
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammatory muscle and connective tissue diseases, neurodegenerative diseases, respiratory diseases, and viral diseases, all the foregoing relating to cell proliferation in humans

Classification kind code

11

Mark Details

Serial Number

1878130

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 191
on 12th Feb 2020		Registration Fee Notice Sent
Submitted for opposition 42
on 20th Nov 2019		Advertised
Submitted for opposition 26
on 4th Nov 2019		Approved
Submitted for opposition 27
on 4th Nov 2019		Approval Notice Sent
Submitted for opposition 14
on 8th Oct 2019		Default Notice Sent
Submitted for opposition 22
on 19th Mar 2019		Search Recorded
Submitted for opposition 20
on 19th Mar 2019		Examiner's First Report
Submitted for opposition 31
on 24th Jan 2018		Formalized
Submitted for opposition 30
on 18th Jan 2018		Filed
Submitted for opposition 1
on 18th Jan 2018		Created